Free Trial
$100 Off. Every Year. Lock In MarketBeat All Access at $149
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Claim the Rate Lock
Claim MarketBeat All Access Sale Promotion

What Symrise (SY1) Said on Its Q3 Earnings Call

Symrise logo with Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Q3 organic sales grew 5.3% to more than €1.3 billion, driven by 6.1% volume growth across both segments; Asia-Pacific led regional performance with 12.1% growth.
  • Symrise reaffirmed its 2026 outlook of 2%–4% organic sales growth, a 21.5%–22.5% adjusted EBITDA margin and free-cash-flow margin above 14%, while warning that fourth-quarter growth will moderate against tougher comparisons.
  • The company completed its Terpenes divestment and Floral Concept acquisition, while investing in natural fragrances, Aroma Molecules capacity, food technology and artificial intelligence to strengthen its portfolio and support longer-term growth.
  • Interested in Symrise? Here are five stocks we like better.

Symrise ETR: SY1 reported 5.3% organic sales growth in the third quarter of 2026, driven primarily by higher volumes across both operating segments, and reaffirmed its full-year outlook despite expecting growth to moderate in the fourth quarter.

Chief Executive Officer Jean-Yves Parisot said quarterly sales exceeded €1.3 billion. Volume grew 6.1%, while pricing reduced organic growth by 0.8 percentage points. He said customer demand remained healthy and that the company saw positive contributions from all divisions, including a return to growth in Pet Food and Care & Wellness.

Segment and Regional Performance

The Taste, Nutrition & Health segment posted 5.2% organic growth, consisting of 4.8% volume growth and 0.4% positive pricing. Reported sales increased to €790 million from €736 million a year earlier.

Within the segment, Food & Beverage produced mid-single-digit organic growth. Naturals grew at a double-digit rate, Sweet grew at a high-single-digit rate, and Savory recorded mid-single-digit growth. Beverages declined at a low-single-digit rate against a comparison period that had included double-digit growth, according to Parisot.

Pet Food returned to low-single-digit organic growth, supported by volume gains in palatability and pet nutrition. Parisot said pricing in pet nutrition remained negative due to strategic pricing actions, customer mix and product mix, although volumes improved during the quarter. In the question-and-answer session, he said the company sees the pet market as resilient and continues to expand its offering from palatability into nutrition, food protection and health-related solutions.

Scent & Care delivered 5.6% organic growth, with 8.1% volume growth partly offset by 2.5% negative pricing. Reported segment sales rose to €520 million from €487 million in the prior-year quarter.

Consumer Fragrance grew at a high-single-digit rate, while Fine Fragrance returned to low-single-digit growth. Care & Wellness also returned to low-single-digit growth, supported by double-digit growth in Advanced Actives and Probiotics. UV Filters declined at a double-digit rate. Aroma Molecules recorded high-single-digit organic growth, with double-digit growth in Menthol and mid-single-digit growth in Specialty Fragrance Ingredients.

  • Asia-Pacific organic sales growth: 12.1%
  • Latin America organic sales growth: 7.4%
  • North America organic sales growth: 4.8%
  • EAME organic sales growth: 1.7%

Parisot said Asia-Pacific was the company’s strongest region, with double-digit growth in both segments. North American growth was supported by Food & Beverage, Fragrance, Aroma Molecules and Care & Wellness.

Portfolio Changes and Transformation Efforts

Symrise completed the divestment of its Terpenes business in September. The business represented approximately €130 million in annual sales. Parisot said the portfolio effect from the transaction will extend beyond the customary 12-month period because of the structure of the deal and related distribution arrangements.

The company also completed its acquisition of Floral Concept, which it said complements Maison Lautier and expands its premium natural fragrance capabilities. Symrise plans to organize Scent & Care into three divisions: Scent, Care & Wellness, and Aroma Specialties. The new natural ingredients business unit within Scent will bring together Floral Concept and Maison Lautier.

Following the Terpenes divestment, the former Aroma Molecules business is being repositioned as Aroma Specialties. Parisot said the business will focus on “essential ingredients,” where technology and scale support cost competitiveness, and “signature ingredients,” where intellectual property and application expertise can support greater differentiation.

The company is also investing in capacity expansion for Aroma Molecules in India and in chicken taste and nutrition technology at its Food & Beverage facility in Berric, France. It opened a digital and artificial intelligence hub in Chennai to complement its existing hub in Barcelona and expanded its Symvision AI platform for use across the innovation process.

Margins, Costs and Outlook

Symrise reaffirmed its 2026 guidance for organic sales growth of 2% to 4%, an adjusted EBITDA margin of 21.5% to 22.5%, and adjusted business free-cash-flow margin above 14%.

Management expects full-year organic growth near the midpoint of its target range, but said fourth-quarter organic growth will be below the third-quarter level because comparison bases will become more difficult. Parisot told analysts there had been no indication of a demand slowdown or a meaningful pull-forward of customer orders into the third quarter.

The company expects adjusted EBITDA margin to fall in the lower half of its guidance range as it reinvests part of its efficiency gains in information technology, innovation, organizational capabilities and personnel. Parisot cited tariffs, higher prices for certain oil-based raw materials and inbound logistics costs as headwinds, while saying the company is accelerating procurement and operational-excellence initiatives.

He said Symrise aims to return to a 23% EBITDA margin over time and continues to maintain its medium-term organic sales growth target of 5% to 7%. The company’s share buyback program was also progressing and was expected to close by the end of October, according to management.

About Symrise (ETR:SY1)

Symrise AG supplies fragrances, flavorings, cosmetic active ingredients and raw materials, and functional ingredients in Europe, Africa, the Middle East, North America, the Asia Pacific, and Latin America. It operates through two segments, Taste, Nutrition & Health; and Scent & Care. The Taste, Nutrition & Health segment provides functional ingredients and product solutions used in the production of food and beverages; savory flavors; natural and sustainable ingredients for food and beverage manufacturers, baby food, and dietary supplements; product solutions and services for pet food manufacturers; sustainable ingredients and services for fish feed manufacturers to develop solutions for fish and shrimp farms; and probiotics for food supplements and functional foods.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Symrise Right Now?

Before you consider Symrise, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Symrise wasn't on the list.

While Symrise currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines